Compounding pharmacies will no longer be allowed to create semaglutide injections, a generic and cheaper version of Ozempic and Wegovy. This comes after a judge rejected a bid by these pharmacies to ...

Both drugs are based on the compound semaglutide. Hims & Hers (HIMS) has been marketing a compounded version of semaglutide during the shortage. According to the FDA’s website on Wednesday ...

New research found that 137 million Americans are now eligible to take semaglutide, sold under the brand names Ozempic, Wegovy, and Rybelsus. Semaglutide is a drug that’s prescribed to treat ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group. The Food and Drug Administration (FDA) has accepted for review ...

Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug semaglutide, sold under the brand names Ozempic and Wegovy. A federal ...